SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001387131-14-004038
Filing Date
2014-12-09
Accepted
2014-12-09 17:11:55
Documents
2
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q ohrp-10qa_063014.htm 10-Q/A 18389
2 SECOND RESEARCH AGREEMENT, JULY 31, 2013 ex10-45.htm EX-10.45 65534
  Complete submission text file 0001387131-14-004038.txt   85104
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-35963 | Film No.: 141275784
SIC: 2834 Pharmaceutical Preparations